Open access
Open access
Powered by Google Translator Translator

M-A | Efficacy and safety of Roxadustat in patients with chronic kidney disease.

29 Nov, 2022 | 14:00h | UTC

Efficacy and Safety of Roxadustat in Patients with Chronic Kidney Disease: An Updated Meta-Analysis of Randomized Controlled Trials including 6,518 Patients – BioMed Research International

Related:

Roxadustat Versus Epoetin Alfa for Treating Anemia in Patients with Chronic Kidney Disease on Dialysis: Results from the Randomized Phase 3 ROCKIES Study – Journal of the American Society of Nephrology

Roxadustat for Anemia in Patients with Kidney Disease Not Receiving Dialysis – New England Journal of Medicine

Roxadustat Treatment for Anemia in Patients Undergoing Long-Term Dialysis- New England Journal of Medicine

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.